Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsProtocol groupIndolent LymphomasTransplantationDiseaseChronic Lymphocytic Leukemia / Small Lymphocytic LymphomaNHL, B-Cell Type, Follicular Grade I-IIIaStem Cell Transplantation, AllogeneicSubgroupICD10C82.9C91.1-MeSHHematopoietic Stem Cell TransplantationLeukemia, Lymphocytic, Chronic, B-CellLymphoma, FollicularTransplantation ConditioningSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleCyclophosphamideDexamethasoneDimetindenFluconazoleFludarabineFosaprepitantFurosemideGranisetronMesnaParacetamolPrednisoloneRituximabUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleCyclophosphamideDexamethasoneDimetindenFluconazoleFludarabineFosaprepitantFurosemideGranisetronMesnaParacetamolPrednisoloneRituximabUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleCyclophosphamideDexamethasoneDimetindenFluconazoleFludarabineFosaprepitantFurosemideGranisetronMesnaParacetamolPrednisoloneRituximabUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleCyclophosphamideDexamethasoneDimetindenFluconazoleFludarabineFosaprepitantFurosemideGranisetronMesnaParacetamolPrednisoloneRituximabUrsodeoxycholic acidValaciclovirNo. Substances17Protocol classificationTherapy classificationcurrent standardIntensityKonditionierung, nicht-myeloablativ (NMA)Therapy indicationTherapy phaseallogene StammzelltransplantationTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorKhouri IFDiseaseCLL, FL Grad I-IIIa, vor allogener SZTOriginUniversity of Texas M. D. Anderson Cancer Center, Houston, USAProtokolle in Überarbeitung 1 protocol foundRituximab 375 / Fludarabine 30 / Cyclophosphamide 750, follicular lymphoma, stages I–IIIa, Allogeneic Stem Cell Transplantation, NMA (PID3223 V1.0)
